"Strofantin" lāʻau. Na Ke Kumu no ka hoʻohana

Uluwehi O "Strofantin" pili i kekahi pūʻulu o cardiac glycosides. Ua ua pono no ka naau ka hoʻokō 'ole' ē aʻe ma mua o huʻi a maʻi palapala, e like me paroxysmal tachycardia.

Ka medicament "Strofantin" kona kinona kakau ana - he sterile pāʻoihana, o ko lākou physico-Nine Inch ka waiwai o ka aniani moakaka wai e loaʻa ole waihoʻoluʻu. I ka papa kuhikuhiEʻeleu 'Oponopono o ka lāʻau i ka läÿau, o cardiac glycosides loko mai o lāʻau lapaʻau mea kanu strophanthus hua.

Ka medicament "Strofantin", olelo ao no ka hana i hoʻolauna iā 'kona hana produces cardiotonic hookoia, mahuahua ka māmā a me ka mana o ka contraction o ka naʻau nāʻiʻo. Nā glycosides i mea i kekahi hapa o ka lāʻau, hoʻolaulaha loa koko ka leo kipaku no myocardial contraction a me kekahi no kekahi minuke. I ka naʻau ole medicament hoʻokāʻoi aʻe ana i ventricular emptying. Kēia ho'ēmi i kā ka infarction nui, a ho'ēmi i kā kona ka oxygen koi. Ka pākōlea hopena o ka lāʻau ia lŘlŘ loko o ekolu i umi minuke ma hope o ka mea ka hoʻokomo o, a mau kekahi i na la ekolu.

Uluwehi O "Strofantin" manual e wehewehe kona waiwai ma luna o ke kino, i nā mea a pau i ke kumu o pharmacological waiwai i uluhia e ka cardiac glycosides, akā, e like ia, cardiotonic hana o ka lāʻau i ka ikaika, a eia kahi mea akaka loa koke. Ka lapaʻauʻia, he uuku ia i ka myocardium pāpana, a 'aʻole i ālai ia' aʻe me ka conduction o impulses i loko o ka pua lala hihia. E hoomakaukau ai "Strofantin" aʻo i wehewehe i ke ano o kona hoʻohana 'ana, ua lawelawe intravenously ma ka liʻiliʻi nā māhele. No ka mea, o ka instability o kona, oia i hoike iki pākōlea hopena, i ka wa lawelawe. Ka lāʻau 'Aʻole i loaa i loko o ke kino, nae, hiki i kaʻawahia i loko o naoh AaOIeIOUIeXAOAaIN me ka digitalis lāʻau. E pale ia keia kanawai, ka mea, ua injected intravenously wale nō ma hope o digitalis lapaau? Iae. Ka mokuāhana ma Pono e mai ka eha a hiki i na la eono. Ua aneane he kanaha pakeneka o ka lawelawe lāʻau e hoopaa ana i na nā polokina i loaʻa i loko o ke koko wai koko. O ka papa kuhikuhi hana waiwai excreted ma nā puʻupaʻa ua hoʻololiʻia.

Ka medicament "Strofantin" (manual iienuaaaony i ke kumu o pathology i loko i ka mea, ua pono e hoʻohana) ua hōʻike ma ka naau ka hoʻokō 'ole, i ka lua a me ke kolu kahua o ka hoʻonaʻauao loaa i ka maʻi, kāna hana infarction pāpana o supraventricular tachycardia, e like me ka atrial arrhythmias.

Ua hiki ke uku mai i ka lāʻau a me ka undesirableʻaoʻao 'ole ma ke kino. Ma ka hapanui o na hihia, ka mea ana i loko o overdose, kokololio intravenous hooponopono, e like me mahuahua pā lonoaʻili o ke kanaka hoʻomanawanui i ka glycosides. Paha cardiac arrhythmias a me myocardial conduction. Ua mea i hiki i ka diarrhea, ka luaʻi, a nausea, a ma ka maopopo loa pathologies - mesenteric infarction. Malfunction o ke ano nā loko, a me ka Central ko mākou hopohopo'ōnaehana ke ka hopena ma ka nānā o headaches, kaumaha, hallucinations, psychosis, Kanikani'āʻula a me ka pilikia makapō hoʻopilikia. Ma kekahi mau hihia, na kanaka hiki ke hoʻomōhala gynecomastia. Aia ka hoi ka pahiki o allergic reactions.

Uluwehi O "Strofantin" kauoha no ka hoʻohana i ao mai e pili ana i contraindications ka mea,ʻaʻole i hōʻike no myocardial infarction, a me ka huʻi palapala, glycoside intoxication, ventricular tachycardia, haʻi bradycardia, hypercalcemia, a me ka hypokalemia, maʻi sinus maʻi pale, he aneurysm o ka thoracic aorta, atrioventricular aeie ka lua a me ke kolu o degere.